awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36716739-90C21C8B-D2A9-4B95-949F-57805D6CA38D
Q36716739-90C21C8B-D2A9-4B95-949F-57805D6CA38D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36716739-90C21C8B-D2A9-4B95-949F-57805D6CA38D
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment
P2860
Q36716739-90C21C8B-D2A9-4B95-949F-57805D6CA38D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36716739-90C21C8B-D2A9-4B95-949F-57805D6CA38D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0aebf875c5d400a0c97264eaf24cf14f4cb4a4f4
P2860
Multikinase inhibitors: a new option for the treatment of thyroid cancer.